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There exists abundant evidence that
mutations that change the function or
expression of growth-regulatory genes
can lead to progression to a cancerous
phenotype, and the progressive
accumulation of such changes as the
underpinning of tumorigenesis forms
the basis for the somatic mutation
theory (SMT) of cancer [1]. At a molecu-
lar level, that model of tumorigenesis
suggeststhatprogression toacancerous
phenotype can be driven by gain-of-
function in growth-promoting onco-
genes and/or loss-of-function in growth
inhibitory tumor suppressor genes
within somatic cells (a third class of
‘‘stability’’ genes are also a contributor
to tumorigenesis [2] but are not con-
sidered in this paper). A frequently used
analogy for that model compares these
classes of genes to the gas pedal and
brakes of an automobile [2]. However,
there is evidence that this model may
not be sufﬁcient in itself to explain the
development of cancer [3]. For example,
the inﬂuence of the milieu of tumor
development may strongly inﬂuence
its development, and so an alternative
model in which the tissue microenviron-
ment is a critical factor in tumorigenesis
has provided the basis for the tissue
organization ﬁeld theory (TOFT) [4].
Although not all differences between
these theories are irreconcilable, a key
difference between these models is that
quiescence is postulated to be the
default state of ‘‘normal cells’’ in SMT,
whereas proliferation is assumed as the
default state of cells in TOFT [4].
It follows from the requirement for
growth promotion in the SMT that the
default state of the cell is static. Indeed,
it is well established that primary cul-
tured cells from metazoan organisms
fail to proliferate in the absence of
appropriate growth factors. Johnston
et al. have further suggested that cellu-
lar progression to a cancerous pheno-
type may represent a reversion of
metazoan cells to a more primitive evol-
utionary phenotype whose ‘‘freedom to
proliferate’’ occurs at the expense of the
host’s long-term survival [5]. This sug-
gestion is supported by similarities
between the behavior of cancer cells
and the likely behavior of unicellular
ancestors of metazoan organisms, as
in both cases their growth is not subject
to external regulation by other cells.
Again, this phrasing also implies a free-
dom not to proliferate. However, as
pointed out by Soto and Sonnenschein
[4], that freedom does not seem to be
enjoyed even by modern unicellular eu-
karyotes. If the default state of growth is
truly different between unicellular and
multicellular organisms, then it follows
that a profound change in the default
state of cells occurred during evolution
of metazoan organisms and that the
change is reversed in carcinogenesis.
However, there may be another, simpler
explanation that requires considering
the growth-promoting signaling path-
ways from an evolutionary perspective.
The earliest cells would necessarily
have been required to be independently
growing entities limited externally only
by the supply of resources and intern-
ally by their capacity to proliferate. As
also argued by Johnston et al. [5], mil-
lennia of selective pressures in unicel-
lular ancestors of modern eukaryotes
would have favored those that were able
to divide most rapidly. In that way, evol-
ution may have led to the development
of early cells as organisms designed
primarily or entirely to proliferate at
the maximum possible rate. During
the evolution of metazoans, it seems
highly unlikely that complex, ligand-
dependent signaling pathways emerged
de novo as a requirement for growth.
Rather, the most straightforward expla-
nation for their appearance may be that
they evolved from growth-related proc-
esses that already occurred in a ligand-
independent manner in their unicellular
ancestors. There may be any number of
ways that could have been accom-
plished. One such example may be pre-
sented by the membrane-associated Ras
protein and its associated signaling
pathways, which play a vital role in cell
cycle progression of both unicellular
organisms and cells of metazoans. At
least in some unicellular organisms
such as yeast, regulation of Ras does
not involve receptors for extracellular
ligands,butratherinvolves intrinsicsig-
nals relating to stress and metabolism
[6]. However, in cells of most or all met-
azoan organisms, Ras acts as a down-
stream effector for growth factor
receptor signaling [7]. Thus, in meta-
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waysmayhavearisenbyco-optingproc-
esses that occurred constitutively in
their unicellular ancestors. In that
sense, ligand binding may not actually
stimulate growth but instead permit it
by completing an interrupted circuit, in
the same way that turning on a light
switch permits the ﬂow of electricity
to light a bulb. It is possible to envision
other scenarios that might also have led
to the appropriation and repurposing of
intracellularprocessestobecomepartof
other ligand-responsive signaling path-
ways in metazoans. In the assessment of
any such potential scenarios, it may be
particularly instructive to analyze the
structure and functions of signaling
pathway components identiﬁed in uni-
cellular organisms that are closely
related to metazoans [8].
If this proposal is correct, then the
function of ligand-stimulated signaling
pathways could be viewed not as a sys-
tem wherein growth factors can be
added to promote growth but rather as
a system in which growth factors can be
withheld to control growth. Thus, the
quiescence of cultured metazoan cells
in the absence of growth factors would
not reﬂect a passive lack of growth
stimulation but rather an active process
of growth inhibition. Furthermore, such
a model would imply that oncogenes,
which are considered stimulators of
growth, actually function to permit
growth by overcoming limitations
imposed during the transition to
multicellularity.
Although this concept does not
argue against an important role for
genetic changes within cells during pro-
gression to cancer, as proposed in the
SMT, it does support the idea of prolifer-
ation as a default state of cells, as pro-
posed in TOFT [1, 3, 4]. It further
suggests that gene products that appear
to ‘‘promote’’ growth actually act to
reveal the cell’s innate tendency to
grow. Thus, this proposal calls into
question the gas pedal and brake anal-
ogy for cell growth. If it is valid, then
perhaps a better comparison would be a
soapbox racer rolling down a hillside
pathway. In this analogy, the pull of
gravity would represent the innate
tendency to grow. Transient and revers-
ible growth-inhibitory processes (e.g.
absence of ligand) could be incorpor-
ated intothis modelasbrakes thatcould
be applied by the driver. Mechanisms to
permanently halt growth are readily
incorporated into such an analogy by
invoking runaway lanes on one side of
the pathway into which the racer can be
steered and brought to rest off the main
pathway (terminal differentiation), and
by invoking a steep cliff face parallel to
the pathway on the other side over
which the racer could be steered (apop-
tosis). This analogy would also suggest
that at least some limited cell cycle pro-
gression would be required for cell
death, a proposal that is consistent with
observations of cell-cycle progression in
many apoptotic cells [9]. Although
superﬁcially this is a more complicated
analogy than the gas pedal and brake,
this model is still approachable and
more readily accounts for the various
potential fates of the cell. In addition,
this concept may better account for the
evolutionary emergence of growth-fac-
tor dependence in cells of metazoans.
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